Editas Medicine, Inc.
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
Last updated:
Abstract:
CRISPR/Cas-related compositions and methods for treatment of Usher Syndrome and/or Retinitis Pigmentosa are disclosed herein.
Status:
Grant
Type:
Utility
Filling date:
5 Mar 2015
Issue date:
8 Jun 2021